SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
By Philip Blenkinsop, Kate Abnett and Michel Rose BRUSSELS/PARIS (Reuters) -AI, biotech and affordable clean energy will be ...
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Debut, the biotech beauty leader, announced today the launch of BeautyORB™, an AI-powered innovation engine that provides a ...
The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...
24/7 Wall St. on MSN7d
I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the GameThe biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...
"Where AI comes into play is where it's going to allow us to do things expeditiously, and it's going to be more personalized. In other words, if you have a patient with a cancer, we can then use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback